Potential Biomarkers and Therapeutic Targets: Inflammation and Oxidative Stress in Left Carotid Artery Stenosis with Coronary Artery Disease

被引:5
|
作者
Li, Xia [1 ]
Guo, Dianxuan [2 ]
Hu, Youdong [2 ]
Zhou, Hualan [2 ]
Chen, Ying [2 ]
机构
[1] Renci Hosp, Dept Internal Med, Siyang 223700, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Xiamen Rd Branch Hosp, Affiliated Huaian Hosp, Huaian 223002, Peoples R China
关键词
Left carotid artery stenosis; coronary artery disease; inflammation; oxidative stress; biomarkers; therapeutic targets; INVASIVE BYPASS-SURGERY; ELECTRON-SPIN-RESONANCE; NECROSIS-FACTOR-ALPHA; ASSOCIATION; REPERFUSION; ANGIOGRAPHY; DIAGNOSIS; PRESSURE; CELLS;
D O I
10.2174/1381612829666230417100144
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Patients with left carotid artery atherosclerotic stenosis have an increased ischemic stroke risk. Left carotid stenosis, the most common cause of the transient ischemic attack, is related to a higher risk of acute stroke. Left carotid artery stenosis is also associated with cerebral artery infarction. The significant coronary stenosis promotes ST-segment elevation myocardial infarctions. The severe coronary stenosis plays an important role in development and progression of myocardial infarction. However, the dynamic changes of circulating oxidative stress and inflammatory markers in the carotid stenosis combined with coronary artery stenosis are not clear, and it also remains unknown whether mark of oxidative stress and inflammation are potential therapeutic targets for carotid stenosis combined with coronary artery stenosis. Aim This study aims to explore the effects of oxidative stress combined with an inflammatory response on left carotid artery stenosis with coronary artery disease in patients. Methods We, therefore, tested the hypothesis that levels of markers of oxidative stress and inflammation are associated with coexistent severe carotid and coronary artery stenosis in patients. We measured the circulating levels of malondialdehyde (MDA), oxidized low-density lipoprotein (OX-LDL), homocysteine (Hcy), F2-isoprostanes (F2-IsoPs), tumor necrosis factor-alpha (TNF-& alpha;), high-sensitivity C-reactive protein (hs-CRP), prostaglandin E2 (PG-E2) and interferon-gamma (IFN-& gamma;) in patients with combined carotid and coronary artery severe stenosis. We also assessed the relationships among oxidative stress, inflammation, and severe stenosis of the carotid with a coronary artery in patients. Results Levels of MDA, OX-LDL, Hcy, F2-IsoPs, TNF-& alpha;, hs-CRP, PG-E2, and IFN-& gamma; were remarkably increased (P < 0.001) in patients with combined carotid and coronary artery severe stenosis. High levels of oxidative stress and inflammation may be related to severe stenosis of the carotid with coronary arteries in patients. Conclusion Our observations indicated that measurements of oxidative stress and inflammatory markers may be valuable for the assessment of the degree of carotid with coronary artery stenosis. The biomarkers of oxidative stress and inflammatory response may become therapeutic targets for carotid artery stenosis with coronary artery stenosis in patients.
引用
收藏
页码:966 / 979
页数:14
相关论文
共 50 条
  • [21] Association between critical left main coronary artery and internal carotid artery stenosis
    AntoniniCanterin, F
    Pezzetta, F
    Burelli, C
    Nicolosi, GL
    Cassin, M
    Pavan, D
    Cervesato, E
    Zanuttini, D
    CIRCULATION, 1996, 94 (08) : 2842 - 2842
  • [22] Inflammatory biomarkers and carotid artery stenosis
    Ben Assayag, E.
    Berliner, S.
    Bova, I.
    Shapira, I.
    Bornstein, N. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 285 - 285
  • [23] Carotid stenosis and peripheral artery disease in Japanese patients with coronary artery disease undergoing coronary artery bypass grafting
    Kawarada, O
    Yokoi, Y
    Morioka, N
    Nakata, S
    Higashiue, S
    Mori, T
    Iwahashi, M
    Hatada, A
    CIRCULATION JOURNAL, 2003, 67 (12) : 1003 - 1006
  • [24] Elective stenting of carotid artery stenosis in patients with severe coronary artery disease
    Waigand, J
    Gross, CM
    Uhlich, F
    Kramer, J
    Tamaschke, C
    Vogel, P
    Luft, FC
    Dietz, R
    EUROPEAN HEART JOURNAL, 1998, 19 (09) : 1365 - 1370
  • [25] CAROTID-ARTERY STENOSIS - ASSOCIATION WITH SURGERY FOR CORONARY-ARTERY DISEASE
    BERNHARD, VM
    JOHNSON, WD
    PETERSON, JJ
    ARCHIVES OF SURGERY, 1972, 105 (06) : 837 - 840
  • [26] Prevalence of carotid artery stenosis in patients with coronary artery disease using duplex carotid ultrasonography
    Norwa-Otto, Bozena
    Kadziela, Jacek
    Dabrowski, Marek
    Debski, Artur
    Pregowski, Jerzy
    Witkowski, Adam
    Piotrowski, Walerian
    Ruzyllo, Witold
    JOURNAL OF HYPERTENSION, 2006, 24 : 169 - 169
  • [27] Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population
    Tanimoto, S
    Ikari, Y
    Tanabe, K
    Yachi, S
    Nakajima, H
    Nakayama, T
    Hatori, M
    Nakazawa, G
    Onuma, Y
    Higashikuni, Y
    Yamamoto, H
    Tooda, E
    Hara, K
    STROKE, 2005, 36 (10) : 2094 - 2098
  • [28] The Early Effect of Carotid Artery Stenting on Antioxidant Capacity and Oxidative Stress in Patients with Carotid Artery Stenosis
    Michalak, Slawomir
    Ambrosius, Wojciech
    Wysocka, Ewa
    Dziarmaga, Mieczyslaw
    Juszkat, Robert
    Wykretowicz, Andrzej
    Kozubski, Wojciech
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [29] The plasma and tissue oxidative status in patients with coronary artery disease: oxidative stress and coronary artery disease
    Demirbag, Recep
    Rabus, Buelent
    Sezen, Yusuf
    Taskin, Abdullah
    Kalayci, Serap
    Balkanay, Mehmet
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 18 (02): : 79 - 82
  • [30] Two Reflections about Amadori Products: Biomarkers or Therapeutic Targets for Coronary Artery Disease?
    Alvarez, Ezequiel
    CARDIOLOGY, 2012, 123 (02) : 81 - 83